Primary endpoints for randomised trials of cancer therapy

被引:27
作者
Cuzick, Jack [1 ]
机构
[1] Queen Mary Univ London, Canc Res UK Ctr Epidemiol Math & Stat, Wolfson Inst Prevent Med, London EC1M 6BQ, England
关键词
D O I
10.1016/S0140-6736(08)60933-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2156 / 2158
页数:3
相关论文
共 12 条
[1]  
Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0
[2]   Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer:: Update of study BIG 1-98 [J].
Coates, Alan S. ;
Keshaviah, Aparna ;
Thuerlimann, Beat ;
Mouridsen, Henning ;
Mauriac, Louis ;
Forbes, John F. ;
Paridaens, Robert ;
Castiglione-Gertsch, Monica ;
Gelber, Richard D. ;
Colleoni, Marco ;
Lang, Istvan ;
Del Mastro, Lucia ;
Smith, Ian ;
Chirgwin, Jacquie ;
Nogaret, Jean-Marie ;
Pienkowski, Tadeusz ;
Wardley, Andrew ;
Jakobsen, Erik H. ;
Price, Karen N. ;
Goldhirsch, Aron .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) :486-492
[3]   Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial [J].
Coombes, R. C. ;
Kilburn, L. S. ;
Snowdon, C. F. ;
Paridaens, R. ;
Coleman, R. E. ;
Jones, S. E. ;
Jassem, J. ;
Van de Velde, C. J. H. ;
Delozier, T. ;
Alvarez, I. ;
Del Mastro, L. ;
Ortmann, O. ;
Diedrich, K. ;
Coates, A. S. ;
Bajetta, E. ;
Holmberg, S. B. ;
Dodwell, D. ;
Mickiewicz, E. ;
Andersen, J. ;
Lonning, P. E. ;
Cocconi, G. ;
Forbes, J. ;
Castiglione, M. ;
Stuart, N. ;
Stewart, A. ;
Fallowfield, L. J. ;
Bertelli, G. ;
Hall, E. ;
Bogle, R. G. ;
Carpentieri, M. ;
Colajori, E. ;
Subar, M. ;
Ireland, E. ;
Bliss, J. M. .
LANCET, 2007, 369 (9561) :559-570
[4]   Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: Updated findings from NCICCTG MA.17 [J].
Goss, PE ;
Ingle, JN ;
Martino, S ;
Robert, NJ ;
Muss, HB ;
Piccart, MJ ;
Castiglione, M ;
Tu, DS ;
Shepherd, LE ;
Pritchard, KI ;
Livingston, RB ;
Davidson, NE ;
Norton, L ;
Perez, EA ;
Abrams, JS ;
Cameron, DA ;
Palmer, MJ ;
Pater, JL .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (17) :1262-1271
[5]   Is screening for breast cancer with mammography justifiable? [J].
Gotzsche, PC ;
Olsen, O .
LANCET, 2000, 355 (9198) :129-134
[6]  
Hanrahan EO, 2007, J CLIN ONCOL, V25, P4952, DOI 10.1200/JCO.2006.08.0499
[7]   Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: The STEEP system [J].
Hudis, Clifford A. ;
Barlow, William E. ;
Costantino, Joseph P. ;
Gray, Robert J. ;
Pritchard, Kathleen I. ;
Chapman, Judith-Anne W. ;
Sparano, Joseph A. ;
Hunsberger, Sally ;
Enos, Rebecca A. ;
Gelber, Richard D. ;
Zujewski, Jo Anne .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (15) :2127-2132
[8]   Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial [J].
Jakesz, R ;
Jonat, W ;
Gnant, M ;
Mittlboeck, M ;
Greil, R ;
Tausch, C ;
Hilfrich, J ;
Kwasny, W ;
Menzel, C ;
Samonigg, H ;
Seifert, M ;
Gademann, G ;
Kaufmann, M .
LANCET, 2005, 366 (9484) :455-462
[9]   Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: Results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a [J].
Jakesz, Raimund ;
Greil, Richard ;
Gnant, Michael ;
Schmid, Marianne ;
Kwasny, Werner ;
Kubista, Ernst ;
Mineritsch, Brigitte ;
Tausch, Christoph ;
Stierer, Michael ;
Hofbauer, Friedrich ;
Renner, Karl ;
Dadak, Christian ;
Ruecklinger, Ernst ;
Samonigg, Hellmut .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (24) :1845-1853
[10]   Endpoints in adjuvant treatment trials:: A systematic review of the literature in colon cancer and proposed definitions for future trials [J].
Punt, Cornelis J. A. ;
Buyse, Marc ;
Kohne, Claus-Henning ;
Hohenberger, Peter ;
Labianca, Roberto ;
Schmoll, Hans J. ;
Pahlman, Lars ;
Sobrero, Alberto ;
Douillard, Jean-Yves .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (13) :998-1003